Muscarinic blockade with oral hyoscine palliates angiotensin converting enzyme inhibitor induced cough.
Adigun
A O
AO
Ajayi
A A
AA
D000284:Administration, Oral; D000368:Aged; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000009:adverse effects*; D003371:Cough / Q000139:chemically induced* / Q000145:classification / Q000188:drug therapy*; D018592:Cross-Over Studies; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D018727:Muscarinic Antagonists / Q000627:therapeutic use*; D009549:Nigeria; D010166:Palliative Care; D012601:Scopolamine / Q000627:therapeutic use*; D012720:Severity of Illness Index; D016037:Single-Blind Method
D000806:Angiotensin-Converting Enzyme Inhibitors; D018727:Muscarinic Antagonists; D012601:Scopolamine